Skip to main content

Table 3 Comparison between AML cases vs. control group regarding pretreatment METTL3 gene expression level at diagnosis

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

METTL3 gene expression (pretreatment level) AML group (n = 40) Control group (n = 20) z test p value
Median (IQR) 6.95 (2.5–10.5) 1.18 (0.5–1.9) 18.544 < 0.001**
  1. IQR interquartile range, z Mann–Whitney test, HS highly significant
  2. **p value < 0.001